Back to Search
Start Over
Cumulative live birth rates in low-prognosis women
- Source :
- Human reproduction (Oxford, England), 34(6):dez051, 1030-1041. Oxford University Press, Human Reproduction, 34(6), 1030-1041. Oxford University Press, Leijdekkers, J A, Eijkemans, M J C, van Tilborg, T C, Oudshoorn, S C, van Golde, R J T, Hoek, A, Lambalk, C B, de Bruin, J P, Fleischer, K, Mochtar, M H, Kuchenbecker, W K H, Laven, J S E, Mol, B W J, Torrance, H L, Broekmans, F J M, Koks, C A M, Verhoeve, H R, Nap, A W, Scheffer, G J, Manger, A P, Schoot, B C, Oosterhuis, G J E, Sluijmer, A V, Friederich, J, Verhoeff, A, van Hooff, M H A, van Santbrink, E J P, Brinkhuis, E A, Smeenk, J M J, Kwee, J, Dekoning, C H, Groen, H & van Wely, M 2019, ' Cumulative live birth rates in low-prognosis women ', Human Reproduction, vol. 34, no. 6, pp. 1030-1041 . https://doi.org/10.1093/humrep/dez051, Human Reproduction, 34, 1030-1041, Human Reproduction (Oxford, England), Human Reproduction, 34, 6, pp. 1030-1041
- Publication Year :
- 2019
-
Abstract
- STUDY QUESTION: Do cumulative live birth rates (CLBRs) over multiple IVF/ICSI cycles confirm the low prognosis in women stratified according to the POSEIDON criteria? SUMMARY ANSWER: The CLBR of low-prognosis women is ~56% over 18 months of IVF/ICSI treatment and varies between the POSEIDON groups, which is primarily attributable to the impact of female age. WHAT IS KNOWN ALREADY: The POSEIDON group recently proposed a new stratification for low-prognosis women in IVF/ICSI treatment, with the aim to define more homogenous populations for clinical trials and stimulate a patient-tailored therapeutic approach. These new criteria combine qualitative and quantitative parameters to create four groups of low-prognosis women with supposedly similar biologic characteristics. STUDY DESIGN, SIZE, DURATION: This study analyzed the data of a Dutch multicenter observational cohort study including 551 low-prognosis women, aged
- Subjects :
- GNRH AGONIST
STIMULATION
medicine.medical_specialty
anti-Mullerian hormone
Cost effectiveness
Reproductive medicine
Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18]
ovarian reserve
OVARIAN RESPONSE
POOR RESPONSE
COST-EFFECTIVENESS
03 medical and health sciences
cumulative live birth
0302 clinical medicine
HORMONE
Obstetrics and gynaecology
poor ovarian response
medicine
Cumulative incidence
Ovarian reserve
030304 developmental biology
0303 health sciences
030219 obstetrics & reproductive medicine
business.industry
IVF/ICSI
Rehabilitation
STARTING IVF/ICSI
Obstetrics and Gynecology
ovarian stimulation
3. Good health
Clinical trial
POSEIDON criteria
female age
Bologna criteria
anti-Müllerian hormone
Reproductive Medicine
IVF
Infertility
low prognosis
Original Article
Live birth
business
IN-VITRO FERTILIZATION
ANTRAL FOLLICLE COUNT
Cohort study
Demography
Subjects
Details
- Language :
- English
- ISSN :
- 02681161
- Volume :
- 34
- Issue :
- 6
- Database :
- OpenAIRE
- Journal :
- Human Reproduction
- Accession number :
- edsair.doi.dedup.....3e8af2b6d2c4fdfb4db98c6904b6573a
- Full Text :
- https://doi.org/10.1093/humrep/dez051